Opportunities and challenges in combination gene cancer therapy.

Opportunities and challenges in combination gene cancer therapy.

Item
http://www.wikidata.org/entity/Q37118663
Adverse Events and Efficacy of Cixutumumab in Phase II Clinical Trials: A systematic Review and Meta-Analysis.siRNA-loaded poly(histidine-arginine)6-modified chitosan nanoparticle with enhanced cell-penetrating and endosomal escape capacities for suppressing breast tumor metastasis.Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics.Progress in nonviral gene therapy for breast cancer and what comes next?Nanomaterial-Enabled Cancer Therapy.DNA/RNA-based formulations for treatment of breast cancer.Multifunctionalized polyethyleneimine-based nanocarriers for gene and chemotherapeutic drug combination therapy through one-step assembly strategy.RNA interference-based therapy and its delivery systems.Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy.
P2860

Opportunities and challenges in combination gene cancer therapy.

Item
http://www.wikidata.org/entity/Q37118663
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Opportunities and challenges in combination gene cancer therapy.
@en
Opportunities and challenges in combination gene cancer therapy.
@nl
type
label
Opportunities and challenges in combination gene cancer therapy.
@en
Opportunities and challenges in combination gene cancer therapy.
@nl
prefLabel
Opportunities and challenges in combination gene cancer therapy.
@en
Opportunities and challenges in combination gene cancer therapy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P932
P356
P1433
P1476
Opportunities and challenges in combination gene cancer therapy.
@en
P2093
P2860
P304
P31
P356
10.1016/J.ADDR.2015.12.005
P407
P478
P577
P698
P932